Main text
(Molecular Therapy: Oncolytics 25, 335–349; June 2022)
Due to a supplier copyediting error, in the originally published version of this article, the GMP acronym in the abstract was defined as “guanosine monophosphate,” and in all the cases in this article the meaning should be “good manufacturing practice.”
In addition, the ScFv clone of ARI-0001 should be A3B1 instead of A1B6 as indicated in the first result.
These errors have been corrected online. Cell Press apologizes for any inconvenience caused.
Contributor Information
María Tristán-Manzano, Email: maria.tristan@genyo.es.
Francisco Martin, Email: francisco.martin@genyo.es.